TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells von Anania, M C, Sensi, M, Radaelli, E, Miranda, C, Vizioli, M G, Pagliardini, S, Favini, E, Cleris, L, Supino, R, Formelli, F, Borrello, M G, Pierotti, M A, Greco, A

Volltext

BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts von Locatelli, S L, Cleris, L, Stirparo, G G, Tartari, S, Saba, E, Pierdominici, M, Malorni, W, Carbone, A, Anichini, A, Carlo-Stella, C

Volltext

IGFBP7: an oncosuppressor gene in thyroid carcinogenesis von Vizioli, M G, Sensi, M, Miranda, C, Cleris, L, Formelli, F, Anania, M C, Pierotti, M A, Greco, A

Volltext

Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts von Locatelli, S L, Giacomini, A, Guidetti, A, Cleris, L, Mortarini, R, Anichini, A, Gianni, A M, Carlo-Stella, C

Volltext

Targeting COPZ1 in thyroid tumour cells von Anania, M.C, Cetti, E, Lecis, D, Cleris, L, Mazzoni, M, Pagliardini, S, Manenti, G, Greco, A

Volltext

48 Proffered Paper: The BH3-only Protein Bim Plays a Critical Role in Hodgkin Lymphoma Cell Death Triggered by the HDAC Inhibitor Givinostat and the Multikinase Inhibitor Sorafenib von Locatelli, S.L, Guidetti, A, Cleris, L, Gianni, A.M, Anichini, A, Carlo-Stella, C

Volltext

174 Quantification of 3D Tumor Vessel Networks by Vessel Caliber, Amount and Distribution, Allows Comparison Among Effects of Vascular-targeted Therapies von Righi, M, Giacomini, A, Cleris, L, Gianni, A.M, Carlo-Stella, C

Volltext

960 Combining Vascular Disruption Activity of TRAIL-expressing CD34+ Cells With Antiangiogenic Activity of Sorafenib Improves Regression of Tumor Growth von Giacomini, A, Lavazza, C, Grazia, G, Locatelli, S.L, Cleris, L, Righi, M, Gianni, A.M, Carlo-Stella, C

Volltext

Growth‐inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement von Greco, A., Roccato, E., Miranda, C., Cleris, L., Formelli, F., Pierotti, M.A.

Volltext

236 (PB224): Tazemetostat and doxorubicin combined treatment in patient-derived preclinical models of epithelioid sarcoma von Soffientini, C., Arrighetti, N., Zuco, V., Cleris, L., Sigalotti, L., Maestro, R., Percio, S., Barisella, M., Collini, P., Dagrada, G.P., Frezza, A.M., Gronchi, A., Pasquali, S., Stacchiotti, S., Zaffaroni, N.

Volltext

Therapeutic effects of the combination of fenretinide and all- trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin... von Formelli, F, Cleris, L

Volltext

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells von Zuco, Valentina, Supino, Rosanna, Righetti, Sabina C, Cleris, Loredana, Marchesi, Edoardo, Gambacorti-Passerini, Carlo, Formelli, Franca

Volltext

439 - Targeting COPZ1 in thyroid tumour cells von Anania, M.C., Cetti, E., Lecis, D., Cleris, L., Mazzoni, M., Pagliardini, S., Manenti, G., Greco, A.

Volltext

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line von APPIERTO, V, CAVADINI, E, PERGOLIZZI, R, CLERIS, L, LOTAN, R, CANEVARI, S, FORMELLI, F

Volltext

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor von LE COUTRE, P, MOLOGNI, L, CLERIS, L, MARCHESI, E, BUCHDUNGER, E, GIARDINI, R, FORMELLI, F, GAMBACORTI-PASSERINI, C

Volltext

Effect of imatinib on haematopoietic recovery following idarubicin exposure von RUCHATZ, H, PUTTINI, M, CLERIS, L, PILOTTI, S, GAMBACORTI-PJSSERINI, C, FORMELLI, F

Volltext

Growth-inhibitory effect of STI571 on cells transformed by theCOL1A1/PDGFB rearrangement von Greco, A., Roccato, E., Miranda, C., Cleris, L., Formelli, F., Pierotti, M.A.

Volltext

The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese di... von CARLO-STELLA, Carmelo, DI NICOLA, Massimo, NAGY, Zoltan, GIOFFRE, Walter R, FORMELLI, Franca, GIANNI, Alessandro M, TURCO, Maria Caterina, CLERIS, Loredana, LAVAZZA, Cristiana, LONGONI, Paolo, MILANESI, Marco, MAGNI, Michele, AMMIRANTE, Massimo, LEONE, Arturo

Volltext

Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity von FORMELLI, F, CLERIS, L

Volltext

Characterization of compound 584, an Abl kinase inhibitor with lasting effects von Puttini, Miriam, Redaelli, Sara, Moretti, Loris, Brussolo, Stefania, Gunby, Rosalind H, Mologni, Luca, Marchesi, Edoardo, Cleris, Loredana, Donella-Deana, Arianna, Drueckes, Peter, Sala, Elisa, Lucchini, Vittorio, Kubbutat, Michael, Formelli, Franca, Zambon, Alfonso, Scapozza, Leonardo, Gambacorti-Passerini, Carlo

Volltext